EBITDA Summary of Beijing Science Sun Pharmaceutical Co., Ltd.

Beijing Science Sun Pharmaceutical Co., Ltd.'s latest annual EBITDA in 2023 was 7.7 Million CNY , down -126.47% from previous year.
Beijing Science Sun Pharmaceutical Co., Ltd.'s latest quarterly EBITDA in 2024 Q3 was 7.91 Million CNY , up 99.13% from previous quarter.
Beijing Science Sun Pharmaceutical Co., Ltd. reported an annual EBITDA of 71.63 Million CNY in 2022, down -81.46% from previous year.
Beijing Science Sun Pharmaceutical Co., Ltd. reported an annual EBITDA of 451.22 Million CNY in 2021, up 101.19% from previous year.
Beijing Science Sun Pharmaceutical Co., Ltd. reported a quarterly EBITDA of -55.16 Million CNY for 2024 Q2, down -38.48% from previous quarter.
Beijing Science Sun Pharmaceutical Co., Ltd. reported a quarterly EBITDA of 155.24 Million CNY for 2024 Q1, up 113.77% from previous quarter.

Annual EBITDA Chart of Beijing Science Sun Pharmaceutical Co., Ltd. (2023 - 2011)

Historical Annual EBITDA of Beijing Science Sun Pharmaceutical Co., Ltd. (2023 - 2011)

Year	EBITDA	EBITDA Growth
2023	7.7 Million CNY	-126.47%
2022	71.63 Million CNY	-81.46%
2021	451.22 Million CNY	101.19%
2020	160.54 Million CNY	49.06%
2019	158.36 Million CNY	-53.96%
2018	326.81 Million CNY	5.67%
2017	305.95 Million CNY	16.92%
2016	264.44 Million CNY	13.67%
2015	232.24 Million CNY	-0.91%
2014	234.72 Million CNY	22.42%
2013	189.41 Million CNY	24.41%
2012	154.43 Million CNY	66.09%
2011	92.73 Million CNY	0.0%

Year	EBITDA	EBITDA Growth
2024 Q3	7.91 Million CNY	99.13%
2024 Q2	-55.16 Million CNY	-38.48%
2024 Q1	155.24 Million CNY	113.77%
2023 Q3	-138.22 Million CNY	-553.82%
2023 Q4	33.94 Million CNY	124.56%
2023 FY	- CNY	-126.47%
2023 Q1	2.93 Million CNY	-97.91%
2023 Q2	30.45 Million CNY	939.16%
2022 FY	- CNY	-81.46%
2022 Q2	63.65 Million CNY	240.69%
2022 Q1	-45.24 Million CNY	-113.19%
2022 Q4	140.31 Million CNY	214.41%
2022 Q3	-122.64 Million CNY	-292.69%
2021 Q2	-2 Million CNY	-112.05%
2021 Q4	342.96 Million CNY	804.15%
2021 Q1	16.65 Million CNY	-80.59%
2021 FY	- CNY	101.19%
2021 Q3	37.93 Million CNY	1989.42%
2020 Q1	9.11 Million CNY	4.44%
2020 FY	- CNY	49.06%
2020 Q4	85.79 Million CNY	161.69%
2020 Q3	32.78 Million CNY	-45.02%
2020 Q2	59.62 Million CNY	554.33%
2019 FY	- CNY	-53.96%
2019 Q4	8.72 Million CNY	-65.18%
2019 Q3	25.06 Million CNY	-57.38%
2019 Q2	58.8 Million CNY	83.62%
2019 Q1	32.02 Million CNY	-59.69%
2018 FY	- CNY	5.67%
2018 Q4	79.44 Million CNY	-8.02%
2018 Q3	86.37 Million CNY	29.07%
2018 Q2	66.91 Million CNY	-6.18%
2018 Q1	71.32 Million CNY	-6.41%
2017 Q1	43.47 Million CNY	17.85%
2017 FY	- CNY	16.92%
2017 Q3	104.55 Million CNY	56.51%
2017 Q4	76.21 Million CNY	-27.11%
2017 Q2	66.8 Million CNY	53.67%
2016 Q3	77.46 Million CNY	0.84%
2016 Q2	76.81 Million CNY	40.37%
2016 Q1	54.72 Million CNY	8.25%
2016 FY	- CNY	13.67%
2016 Q4	36.88 Million CNY	-52.38%
2015 Q2	-19.93 Million CNY	-115.07%
2015 FY	- CNY	-0.91%
2015 Q4	50.55 Million CNY	-2.06%
2015 Q3	51.61 Million CNY	358.95%
2015 Q1	132.31 Million CNY	172.14%
2014 Q1	117.44 Million CNY	0.0%
2014 Q2	-7.55 Million CNY	-106.43%
2014 Q4	48.61 Million CNY	-17.5%
2014 FY	- CNY	22.42%
2014 Q3	58.92 Million CNY	880.36%
2013 FY	- CNY	24.41%
2012 FY	- CNY	66.09%
2011 FY	- CNY	0.0%

Peer EBITDA Comparison of Beijing Science Sun Pharmaceutical Co., Ltd.

Name	EBITDA	EBITDA Difference
Shenzhen Kangtai Biological Products Co., Ltd.	1.29 Billion CNY	99.405%
PharmaBlock Sciences (Nanjing), Inc.	380.8 Million CNY	97.977%
Shandong Shanda Wit Science and Technology Co., Ltd.	1.39 Billion CNY	99.449%
Pacific Shuanglin Bio-pharmacy Co., LTD	841.98 Million CNY	99.085%
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd	217.47 Million CNY	96.458%
Jilin Aodong Pharmaceutical Group Co., Ltd.	1.87 Billion CNY	99.59%
Chengdu Huasun Technology Group Inc., Ltd.	74.04 Million CNY	89.597%
Zhejiang AngLiKang Pharmaceutical CO.,LTD.	300.14 Million CNY	97.434%
Hengkang Medical Group Co., Ltd.	348.09 Million CNY	97.787%
Anhui Huangshan Capsule Co., Ltd.	118.18 Million CNY	93.482%
Walvax Biotechnology Co., Ltd.	938.22 Million CNY	99.179%
Tianjin Ringpu Bio-Technology Co.,Ltd.	711.43 Million CNY	98.917%
Anhui Fengyuan Pharmaceutical Co., Ltd.	388.66 Million CNY	98.018%
Apeloa Pharmaceutical Co.,Ltd	1.79 Billion CNY	99.57%
Harbin Gloria Pharmaceuticals Co., Ltd	275.28 Million CNY	97.202%
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.	4.68 Billion CNY	99.836%
Hunan Hansen Pharmaceutical Co., Ltd.	280.66 Million CNY	97.255%
Xiamen Kingdomway Group Company	588.78 Million CNY	98.692%
Zhejiang Tianyu Pharmaceutical Co., Ltd.	435.22 Million CNY	98.23%
Zhuhai Rundu Pharmaceutical Co., Ltd.	215.02 Million CNY	96.418%
Hainan Haiyao Co., Ltd.	152.19 Million CNY	94.939%
Shenzhen Neptunus Bioengineering Co., Ltd.	-141.51 Million CNY	105.443%
Fujian Cosunter Pharmaceutical Co., Ltd.	-190.85 Million CNY	104.036%
Huapont Life Sciences Co., Ltd.	2.12 Billion CNY	99.638%
Livzon Pharmaceutical Group Inc.	3.29 Billion CNY	99.766%
Honz Pharmaceutical Co., Ltd.	133.53 Million CNY	94.231%
Northeast Pharmaceutical Group Co., Ltd.	1.19 Billion CNY	99.356%
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.	124.71 Million CNY	93.824%
Hainan Poly Pharm. Co., Ltd	309.33 Million CNY	97.51%
Sunflower Pharmaceutical Group Co.,Ltd	1.54 Billion CNY	99.502%
Zhejiang Jingxin Pharmaceutical Co., Ltd.	945.42 Million CNY	99.185%
Kunming Longjin Pharmaceutical Co., Ltd.	-31.19 Million CNY	124.691%
Zhejiang Hisoar Pharmaceutical Co., Ltd.	-43.99 Million CNY	117.509%
Zhejiang Yatai Pharmaceutical Co., Ltd.	76.31 Million CNY	89.906%
Zhejiang NHU Company Ltd.	5.24 Billion CNY	99.853%
Zhejiang Xinguang Pharmaceutical Co., Ltd.	87.94 Million CNY	91.242%
Jiuzhitang Co., Ltd.	460.28 Million CNY	98.326%
Qianjiang Yongan Pharmaceutical Co., Ltd.	141.6 Million CNY	94.56%
Jinghua Pharmaceutical Group Co., Ltd.	417.61 Million CNY	98.155%
Hunan Er-Kang Pharmaceutical Co., Ltd	12.02 Million CNY	35.928%
Yunnan Baiyao Group Co.,Ltd	5.2 Billion CNY	99.852%
ApicHope Pharmaceutical Co., Ltd	464.04 Million CNY	98.34%
Shandong Wohua Pharmaceutical Co., Ltd.	87.98 Million CNY	91.246%
Jinling Pharmaceutical Company Limited	249.63 Million CNY	96.914%
Beijing SL Pharmaceutical Co., Ltd.	610.29 Million CNY	98.738%
Shanxi Zhendong Pharmaceutical Co.,Ltd	94.75 Million CNY	91.87%
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd	166.4 Million CNY	95.371%
Huaren Pharmaceutical Co., Ltd.	431.65 Million CNY	98.215%
Betta Pharmaceuticals Co., Ltd.	696.09 Million CNY	98.893%
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD	127.72 Million CNY	93.969%
Changzhou Qianhong Biopharma CO.,LTD	278.66 Million CNY	97.236%
Chengdu Kanghong Pharmaceutical Group Co., Ltd	1.38 Billion CNY	99.445%
Changjiang Pharmaceutical Group Co., Ltd.	-572.69 Million CNY	101.345%
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd.	228.9 Million CNY	96.635%
Zhejiang Garden Bio-chemical High-tech Co., Ltd.	383.11 Million CNY	97.989%
Tianjin Lisheng Pharmaceutical Co.,Ltd.	477.37 Million CNY	98.386%
Guangdong Lifestrong Pharmacy Co., Ltd.	50.95 Million CNY	84.884%
Huadong Medicine Co., Ltd	4.61 Billion CNY	99.833%
PKU HealthCare Corp.,Ltd.	132.39 Million CNY	94.182%
Hybio Pharmaceutical Co., Ltd.	-233.61 Million CNY	103.297%
Shenzhen Weiguang Biological Products Co., Ltd.	350.21 Million CNY	97.8%
Fuan Pharmaceutical (Group) Co., Ltd.	528.99 Million CNY	98.544%
Jiangsu Nhwa Pharmaceutical Co., LTD	1.33 Billion CNY	99.425%
Harbin Medisan Pharmaceutical Co., Ltd.	183.66 Million CNY	95.806%
Teyi Pharmaceutical Group Co.,Ltd	369.46 Million CNY	97.915%
Tus-Pharmaceutical Group Co., Ltd.	62.18 Million CNY	87.612%
LanZhou Foci Pharmaceutical Co.,Ltd.	135.36 Million CNY	94.31%
Changchun High-Tech Industries (Group) Inc.	6.09 Billion CNY	99.874%
Shanghai Kaibao Pharmaceutical CO.,Ltd	375.33 Million CNY	97.948%
Shandong Xinhua Pharmaceutical Company Limited	1.09 Billion CNY	99.297%
Beijing Beilu Pharmaceutical Co., Ltd	36.44 Million CNY	78.864%
Dezhan Healthcare Company Limited	219.36 Million CNY	96.488%
Tianjin Chase Sun Pharmaceutical Co.,Ltd	1.04 Billion CNY	99.264%
Beijing Aosaikang Pharmaceutical Co., Ltd.	-112.74 Million CNY	106.832%
Jinhe Biotechnology CO., LTD.	345.42 Million CNY	97.77%
Baotou Dongbao Bio-Tech Co.,Ltd	236.24 Million CNY	96.739%
ShanXi C&Y Pharmaceutical Group Co., Ltd.	127.06 Million CNY	93.938%
Tibet AIM Pharm. Inc.	50.76 Million CNY	84.825%
Guangdong Zhongsheng Pharmaceutical Co., Ltd.	453.78 Million CNY	98.302%
Nanjing Hicin Pharmaceutical Co., Ltd.	97 Million CNY	92.059%
Renhe Pharmacy Co., Ltd.	1.05 Billion CNY	99.267%
Wuhan Hiteck Biological Pharma Co.,Ltd	-73.65 Million CNY	110.458%
Guizhou Xinbang Pharmaceutical Co., Ltd.	654.01 Million CNY	98.822%
Dong-E-E-Jiao Co.,Ltd.	1.53 Billion CNY	99.5%
Jiangxi Synergy Pharmaceutical Co., Ltd.	192.54 Million CNY	95.999%
Chongqing Pharscin Pharmaceutical Co., Ltd.	125.84 Million CNY	93.879%
Zhejiang Xianju Pharmaceutical Co.,Ltd.	863.95 Million CNY	99.108%
Luoxin Pharmaceuticals Group Stock Co., Ltd.	-320.08 Million CNY	102.407%
Guizhou Bailing Group Pharmaceutical Co., Ltd.	-298.6 Million CNY	102.58%

Global Stocks Search

Beijing Science Sun Pharmaceutical Co., Ltd. (300485.SZ)

EBITDA Summary of Beijing Science Sun Pharmaceutical Co., Ltd.

Annual EBITDA Chart of Beijing Science Sun Pharmaceutical Co., Ltd. (2023 - 2011)

Historical Annual EBITDA of Beijing Science Sun Pharmaceutical Co., Ltd. (2023 - 2011)

Peer EBITDA Comparison of Beijing Science Sun Pharmaceutical Co., Ltd.